Nektar Therapeutics (Nasdaq:NKTR) announced today that
its corporate presentation will be webcast live from the Bear Biotech
West Coast Confab, Thursday, March 23 beginning at 1:30 p.m. Pacific
Standard Time. The audio-only presentation may be accessed on Nektar's
Investor Relations' page at www.nektar.com and will be available
within 24 hours following the live presentation until April 6, 2006.
Nektar Therapeutics develops and enables high-value, differentiated therapeutics with its industry-leading drug delivery technologies, expertise and manufacturing capabilities. The world's top biotechnology and pharmaceutical companies are developing new and better therapeutics using Nektar's advanced technologies and know-how. Nektar also develops its own products by applying its drug delivery technologies and its expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.
Nektar Therapeutics develops and enables high-value, differentiated therapeutics with its industry-leading drug delivery technologies, expertise and manufacturing capabilities. The world's top biotechnology and pharmaceutical companies are developing new and better therapeutics using Nektar's advanced technologies and know-how. Nektar also develops its own products by applying its drug delivery technologies and its expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.